DBV Technologies S.A (DBVT) Earnings Date & Reports

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

DBVT is expected to report earnings to fall 17.39% to -18 cents per share on July 29

DBV Technologies S.A DBVT Stock Earnings Reports

Q2'24

Est.

$-0.19

Q4'24

Est.

$-0.23

Q1'24

Missed

by $0.05

Q4'23

Beat

by $0.02

Q3'23

Beat

by $0.07

The last earnings report on April 11 showed earnings per share of -23 cents, missing the estimate of -22 cents. With 72.62K shares outstanding, the current market capitalization sits at 222.45M.

View a ticker or compare two or three

Compare

DBVT